GENEVA, Oct. 15 -- LAZULI THERAPEUTICS, INC. filed a patent application (US2026/022645) for “INHIBITORS OF PCSK9 AND USES THEREOF”. With publication no. WO/2026/217545, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07C 13/08
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....